Back

All-cause mortality in post–myocardial infarction patients with reduced LVEF with and without ICD therapy: insights from the PROFID study

28 August 2026 (12:45 - 13:00)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Arrhythmias, Pacing, and Electrophysiology Implantable Cardioverter-Defibrillator (ICD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Toshinori Chiba

Charité - University Medicine Berlin, Berlin (Germany)

3 More presentations in this session

Presentation thumbnail
Empagliflozin to prevent post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (EMPOAF), a randomized, double-blind, placebo-controlled trial
Doctor M. Aghakouchakzadeh (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Splanchnic circulatory failure drives vasovagal syncope: bioimpedance profiling of regional fluid shifts and dose-response characterisation of greater splanchnic nerve stimulation
Doctor M. Zuhair (London, GB)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance-based prediction of ventricular arrhythmic events in non-ischemic cardiomyopathy: derivation and external validation in the international multicenter IMPROVE-NICM Study
Doctor A. Latini (Rozzano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session in Arrhythmias, Pacing, and Electrophysiology
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 12:45 CET
You may be interested in
thumbnail
Congress Presentation
Ongoing trials re-evaluating the primary prevention ICD indication
1 April 2025
thumbnail
Congress Presentation
The final PROFID clinical prediction model.
29 August 2022
thumbnail
Congress Presentation
Evaluation of primary prevention ICD efficacy in late elderly heart failure patients: a multicenter study
28 August 2026
thumbnail
Congress Presentation
Long-term incidence of infective endocarditis according to the type of cardiac implantable electronic device: a nationwide comparison with moderate- and high-risk patient groups
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources